{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T18:44:04Z","timestamp":1743533044270},"reference-count":10,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,14]]},"DOI":"10.1182\/blood.2023021538","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T16:33:27Z","timestamp":1702571607000},"page":"2043-2045","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["HCT alleviates disease burden in CGD"],"prefix":"10.1182","volume":"142","author":[{"given":"Tayfun","family":"G\u00fcng\u00f6r","sequence":"first","affiliation":[{"name":"University Children\u2019s Hospital Z\u00fcrich"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"24","key":"2023121416332047700_bib1","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/blood.2022019586","article-title":"Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD","volume":"142","author":"Leiding","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2023121416332047700_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","article-title":"Chronic granulomatous disease","volume":"27","author":"Holland","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9915","key":"2023121416332047700_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"Gungor","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"2023121416332047700_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2023121416332047700_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2011.10.005","article-title":"Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease","volume":"129","author":"Martinez","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"2023121416332047700_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"issue":"23","key":"2023121416332047700_bib7","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood.2019000021","article-title":"Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center report","volume":"133","author":"Lum","year":"2019","journal-title":"Blood"},{"key":"2023121416332047700_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fped.2020.00327","article-title":"Cellular therapies in chronic granulomatous disease","volume":"8","author":"Gungor","year":"2020","journal-title":"Front Pediatr"},{"issue":"4","key":"2023121416332047700_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10875-020-00772-z","article-title":"Failure\u00a0to prevent severe graft-versus-host disease in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in chronic granulomatous disease","volume":"40","author":"Parta","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"issue":"16","key":"2023121416332047700_bib10","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1182\/bloodadvances.2022009051","article-title":"Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study","volume":"7","author":"Achini-Gutzwiller","year":"2023","journal-title":"Blood Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/24\/2043\/2176461\/blood_bld-2023-021538-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/24\/2043\/2176461\/blood_bld-2023-021538-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T16:33:34Z","timestamp":1702571614000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/24\/2043\/506523\/HCT-alleviates-disease-burden-in-CGD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":10,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,12,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023021538","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]}}}